Emad A. Rakha
#132,457
Most Influential Person Now
Researcher
Emad A. Rakha's AcademicInfluence.com Rankings
Emad A. Rakhaengineering Degrees
Engineering
#4615
World Rank
#5824
Historical Rank
Electrical Engineering
#1186
World Rank
#1273
Historical Rank
Emad A. Rakhacomputer-science Degrees
Computer Science
#5888
World Rank
#6212
Historical Rank
Computational Linguistics
#913
World Rank
#927
Historical Rank
Machine Learning
#1732
World Rank
#1755
Historical Rank
Artificial Intelligence
#1975
World Rank
#2009
Historical Rank
Download Badge
Engineering Computer Science
Emad A. Rakha's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Computer Engineering Cairo University
Similar Degrees You Can Earn
Why Is Emad A. Rakha Influential?
(Suggest an Edit or Addition)Emad A. Rakha's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prognostic markers in triple‐negative breast cancer (2007) (1204)
- Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies (2010) (1025)
- Basal-like breast cancer: a critical review. (2008) (910)
- Breast cancer prognostic classification in the molecular era: the role of histological grade (2010) (749)
- A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal (2018) (636)
- Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists (2011) (629)
- High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses (2005) (596)
- Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients. (2014) (588)
- Prognostic significance of Nottingham histologic grade in invasive breast carcinoma. (2008) (496)
- Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes (2009) (473)
- Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. (2009) (412)
- Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer (2013) (377)
- Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer (2005) (326)
- Phyllodes tumours of the breast: a consensus review (2016) (305)
- Triple‐negative/basal‐like breast cancer: review (2009) (294)
- Biologic and clinical characteristics of breast cancer with single hormone receptor positive phenotype. (2007) (284)
- Estrogen receptor-negative breast carcinomas: a review of morphology and immunophenotypical analysis (2005) (280)
- Combinatorial biomarker expression in breast cancer (2010) (217)
- The prognostic significance of lymphovascular invasion in invasive breast carcinoma (2012) (212)
- Basal phenotype identifies a poor prognostic subgroup of breast cancer of clinical importance. (2006) (207)
- Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes. (2008) (206)
- Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen (2009) (205)
- Updated UK Recommendations for HER2 assessment in breast cancer (2014) (195)
- PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2 (2012) (165)
- Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype (2008) (145)
- Expression of BRCA1 protein in breast cancer and its prognostic significance. (2008) (145)
- An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation (2017) (140)
- Are triple-negative tumours and basal-like breast cancer synonymous? (2007) (140)
- An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens (2006) (138)
- Predictive value of needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening (2008) (135)
- Tubular carcinoma of the breast: further evidence to support its excellent prognosis. (2010) (122)
- Histologic grading is an independent prognostic factor in invasive lobular carcinoma of the breast (2008) (120)
- Lymphatic and blood vessels in basal and triple-negative breast cancers: characteristics and prognostic significance (2011) (119)
- Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer (2012) (117)
- Clinical and Biological Significance of E-cadherin Protein Expression in Invasive Lobular Carcinoma of the Breast (2010) (117)
- Lobular Neoplasia of the Breast Revisited With Emphasis on the Role of E-Cadherin Immunohistochemistry (2013) (117)
- Metastatic triple-negative breast cancer. (2011) (114)
- Encapsulated Papillary Carcinoma of the Breast: An Invasive Tumor With Excellent Prognosis (2011) (114)
- Lobular breast carcinoma and its variants. (2010) (111)
- Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival (2016) (110)
- MIB1/Ki-67 labelling index can classify grade 2 breast cancer into two clinically distinct subgroups (2011) (109)
- The Spectrum of Triple-Negative Breast Disease: High- and Low-Grade Lesions. (2017) (101)
- Nottingham Prognostic Index Plus (NPI+): a modern clinical decision making tool in breast cancer (2014) (101)
- A Case-Controlled Study of the Oncologic Safety of Fat Grafting (2015) (98)
- Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas (2018) (97)
- IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis. (2020) (97)
- The prognostic significance of inflammation and medullary histological type in invasive carcinoma of the breast. (2009) (94)
- A CD44−/CD24+ phenotype is a poor prognostic marker in early invasive breast cancer (2012) (93)
- The prognostic significance of PELP1 expression in invasive breast cancer with emphasis on the ER-positive luminal-like subtype (2010) (92)
- Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening (2011) (92)
- Forkhead-box A1 (FOXA1) expression in breast cancer and its prognostic significance. (2008) (90)
- Basal-like breast carcinoma: from expression profiling to routine practice. (2009) (90)
- Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status (2009) (90)
- Prognostic factors in metaplastic carcinoma of the breast: a multi-institutional study (2014) (89)
- Targeting XRCC1 deficiency in breast cancer for personalized therapy. (2013) (83)
- Loss of Dicer expression is associated with breast cancer progression and recurrence (2012) (83)
- PIK3CA expression in invasive breast cancer: a biomarker of poor prognosis (2010) (82)
- Towards intra-operative diagnosis of tumours during breast conserving surgery by selective-sampling Raman micro-spectroscopy (2014) (82)
- The sensitivity of cytologic evaluation of pleural fluid in the diagnosis of malignant mesothelioma (2010) (81)
- Molecular classification of breast cancer: what the pathologist needs to know. (2017) (81)
- Chromosome 16 tumor‐suppressor genes in breast cancer (2006) (81)
- Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis (2016) (79)
- MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours (2016) (79)
- Patho-biological aspects of basal-like breast cancer (2009) (78)
- The influence of basal phenotype on the metastatic pattern of breast cancer. (2008) (77)
- The role of glutaminase in cancer (2020) (77)
- The updated ASCO/CAP guideline recommendations for HER2 testing in the management of invasive breast cancer: a critical review of their implications for routine practice (2014) (75)
- Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors (2018) (75)
- Clinical and biological significance of glucocorticoid receptor (GR) expression in breast cancer (2015) (74)
- The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours (2018) (74)
- Untangling the ATR‐CHEK1 network for prognostication, prediction and therapeutic target validation in breast cancer (2015) (73)
- FOXO3a nuclear localisation is associated with good prognosis in luminal-like breast cancer (2011) (71)
- Targeting BRCA1‐BER deficient breast cancer by ATM or DNA‐PKcs blockade either alone or in combination with cisplatin for personalized therapy (2015) (70)
- A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks (2010) (70)
- Artificial intelligence in digital breast pathology: Techniques and applications (2019) (69)
- Immune Infiltration in Invasive Lobular Breast Cancer (2018) (68)
- Modern Classification of Breast Cancer: Should we Stick With Morphology or Convert to Molecular Profile Characteristics (2011) (66)
- The prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome (2008) (65)
- A methodology to identify consensus classes from clustering algorithms applied to immunohistochemical data from breast cancer patients (2010) (64)
- Biological and clinical significance of PARP1 protein expression in breast cancer (2014) (63)
- Clinical Outcome of Atypical Endometrial Hyperplasia Diagnosed on an Endometrial Biopsy: Institutional Experience and Review of Literature (2012) (63)
- Expression profiling technology: its contribution to our understanding of breast cancer (2007) (62)
- Loss of expression of chromosome 16q genes DPEP1 and CTCF in lobular carcinoma in situ of the breast (2008) (61)
- Tumour Heterogeneity of Breast Cancer: From Morphology to Personalised Medicine (2018) (61)
- Outcome of breast lesions diagnosed as lesion of uncertain malignant potential (B3) or suspicious of malignancy (B4) on needle core biopsy, including detailed review of epithelial atypia (2011) (60)
- Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer (2013) (60)
- Sonographic correlations with the new molecular classification of invasive breast cancer (2009) (59)
- MYC regulation of glutamine–proline regulatory axis is key in luminal B breast cancer (2017) (58)
- Intra-operative spectroscopic assessment of surgical margins during breast conserving surgery (2018) (58)
- IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients (2017) (58)
- Are Triple-Negative and Basal-Like Breast Cancer Synonymous? (2008) (56)
- Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents (2015) (56)
- Vacuum-assisted excision of breast lesions of uncertain malignant potential (B3) - an alternative to surgery in selected cases. (2008) (56)
- The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer (2010) (56)
- Clinicopathologic and molecular significance of phospho-Akt expression in early invasive breast cancer (2011) (55)
- Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer (2015) (55)
- Heterogeneity of tumour‐infiltrating lymphocytes in breast cancer and its prognostic significance (2018) (55)
- Immunoprofile of metaplastic carcinomas of the breast (2017) (55)
- Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease (2010) (54)
- Prognostic significance of tumor-infiltrating lymphocytes in ductal carcinoma in situ of the breast (2018) (54)
- Expression of CDK7, Cyclin H, and MAT1 Is Elevated in Breast Cancer and Is Prognostic in Estrogen Receptor–Positive Breast Cancer (2016) (54)
- The p53 positive Bcl‐2 negative phenotype is an independent marker of prognosis in breast cancer (2007) (51)
- Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women (2012) (51)
- A critical review why assessment of steroid hormone receptors in breast cancer should be quantitative. (2013) (51)
- KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer (2015) (51)
- RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype (2011) (50)
- The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology (2009) (50)
- Epithelial mesenchymal transition in early invasive breast cancer: an immunohistochemical and reverse phase protein array study (2014) (50)
- The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis‐generating study (2015) (49)
- An approach to the diagnosis of spindle cell lesions of the breast (2016) (49)
- Routine elastic staining assists detection of vascular invasion in colorectal cancer (2006) (49)
- C‐Met in invasive breast cancer (2014) (49)
- Altered glutamine metabolism in breast cancer; subtype dependencies and alternative adaptations (2018) (48)
- Involvement of metformin and AMPK in the radioresponse and prognosis of luminal versus basal-like breast cancer treated with radiotherapy (2014) (48)
- Investigating AP-2 and YY1 protein expression as a cause of high HER2 gene transcription in breast cancers with discordant HER2 gene amplification (2009) (48)
- Clinical Impact of Tumor DNA Repair Expression and T-cell Infiltration in Breast Cancers (2017) (47)
- Identification of key clinical phenotypes of breast cancer using a reduced panel of protein biomarkers (2013) (47)
- Genetic Analysis of Microglandular Adenosis and Acinic Cell Carcinomas of the Breast Provides Evidence for the Existence of a Low-grade Triple-Negative Breast Neoplasia Family (2016) (46)
- Expression of E2F‐4 in invasive breast carcinomas is associated with poor prognosis (2004) (46)
- Overexpression of the cancer stem cell marker CD133 confers a poor prognosis in invasive breast cancer (2018) (45)
- Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ (2017) (45)
- Do primary mammary osteosarcoma and chondrosarcoma exist? A review of a large multi-institutional series of malignant matrix-producing breast tumours. (2013) (45)
- Pitfalls in outcome prediction of breast cancer (2013) (45)
- High‐grade encapsulated papillary carcinoma of the breast: an under‐recognized entity (2015) (45)
- Lymph-node metastases in invasive lobular carcinoma are different from those in ductal carcinoma of the breast (2011) (45)
- The mammographic correlations of a new immunohistochemical classification of invasive breast cancer. (2008) (45)
- Histological features of medullary carcinoma and prognosis in triple-negative basal-like carcinomas of the breast (2010) (45)
- Histological grading of breast cancer on needle core biopsy: the role of immunohistochemical assessment of proliferation (2010) (45)
- Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections (2017) (44)
- Breast carcinoma with basal phenotype: mammographic findings. (2008) (43)
- DNA damage repair in breast cancer and its therapeutic implications. (2017) (43)
- Microglandular adenosis associated with triple‐negative breast cancer is a neoplastic lesion of triple‐negative phenotype harbouring TP53 somatic mutations (2016) (43)
- The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancer (2015) (42)
- Metadherin: A Therapeutic Target in Multiple Cancers (2019) (42)
- Prognostic Role of Androgen Receptor in Triple Negative Breast Cancer: A Multi-Institutional Study (2019) (42)
- Breast cancer intratumour heterogeneity: current status and clinical implications (2018) (42)
- Impact of Basal-Like Breast Carcinoma Determination for a More Specific Therapy (2008) (42)
- Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer (2014) (42)
- Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: a validation cohort (2018) (42)
- Diagnostic challenges in papillary lesions of the breast. (2018) (41)
- RECQL4 helicase has oncogenic potential in sporadic breast cancers (2016) (40)
- Outcome of pure mucocele‐like lesions diagnosed on breast core biopsy (2013) (40)
- Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer (2015) (40)
- Growth fraction as a predictor of response to chemotherapy in node‐negative breast cancer (2010) (39)
- Metaplastic breast carcinoma: tumour histogenesis or dedifferentiation? (2011) (39)
- The oestrogen receptor coactivator CARM1 has an oncogenic effect and is associated with poor prognosis in breast cancer (2013) (39)
- Digital pathology and artificial intelligence will be key to supporting clinical and academic cellular pathology through COVID-19 and future crises: the PathLAKE consortium perspective (2020) (38)
- Clinicopathological Significance of ATM-Chk2 Expression in Sporadic Breast Cancers: a Comprehensive Analysis in Large Cohorts1 (2014) (38)
- Audit of performance of needle core biopsy diagnoses of screen detected breast lesions. (2008) (38)
- Characteristics of basal cytokeratin expression in breast cancer (2013) (38)
- Elevated MMP9 expression in breast cancer is a predictor of shorter patient survival (2020) (37)
- Encapsulated papillary carcinoma of the breast: a study of invasion associated markers (2012) (37)
- The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes (2018) (37)
- Clinical and biological significance of RAD51 expression in breast cancer: a key DNA damage response protein (2016) (35)
- Chk1 phosphorylated at serine345 is a predictor of early local recurrence and radio‐resistance in breast cancer (2016) (35)
- HER2/HER3 heterodimers and p21 expression are capable of predicting adjuvant trastuzumab response in HER2+ breast cancer (2014) (35)
- Inflammatory breast cancer: time to standardise diagnosis assessment and management, and for the joining of forces to facilitate effective research (2015) (35)
- DNA damage response markers are differentially expressed in BRCA-mutated breast cancers (2015) (34)
- TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome (2012) (34)
- Current and future applications of artificial intelligence in pathology: a clinical perspective (2020) (34)
- Expression of the transcription factor CTCF in invasive breast cancer: a candidate gene located at 16q22.1 (2004) (34)
- Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical management (2016) (34)
- Review of the national external quality assessment (EQA) scheme for breast pathology in the UK (2016) (33)
- Nottingham Prognostic Index Plus: Validation of a clinical decision making tool in breast cancer in an independent series (2016) (33)
- Pleomorphic lobular carcinoma of the breast: is it a prognostically significant pathological subtype independent of histological grade? (2013) (33)
- Predictors of pathological complete response to neoadjuvant treatment and changes to post-neoadjuvant HER2 status in HER2-positive invasive breast cancer (2021) (32)
- Expression of Lamin A/C in early-stage breast cancer and its prognostic value (2019) (32)
- Checkpoint kinase1 (CHK1) is an important biomarker in breast cancer having a role in chemotherapy response (2015) (32)
- Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape (2018) (32)
- Torsion of the testicular appendix: importance of associated acute inflammation (2006) (31)
- SUMOylation proteins in breast cancer (2014) (31)
- Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer (2020) (31)
- Histological grade of invasive carcinoma of the breast assessed on needle core biopsy – modifications to mitotic count assessment to improve agreement with surgical specimens (2011) (31)
- National guidelines and level of evidence: comments on some of the new recommendations in the American Society of Clinical Oncology and the College of American Pathologists human epidermal growth factor receptor 2 guidelines for breast cancer. (2015) (31)
- Further evidence that E‐cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study (2013) (31)
- Loss of the Nuclear Pool of Ubiquitin Ligase CHIP/STUB1 in Breast Cancer Unleashes the MZF1-Cathepsin Pro-oncogenic Program. (2018) (30)
- Are acinic cell carcinomas of the breast and salivary glands distinct diseases? (2015) (30)
- Breast tumor microenvironment structures are associated with genomic features and clinical outcome (2022) (30)
- CDC20 expression in oestrogen receptor positive breast cancer predicts poor prognosis and lack of response to endocrine therapy (2019) (30)
- A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk (2019) (30)
- Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer (2012) (30)
- Bimodality of intratumor Ki67 expression is an independent prognostic factor of overall survival in patients with invasive breast carcinoma (2016) (29)
- Combining clustering and classification ensembles: A novel pipeline to identify breast cancer profiles (2019) (29)
- Clinicopathological and prognostic significance of RECQL5 helicase expression in breast cancers. (2016) (29)
- Prognostic significance of cathepsin V (CTSV/CTSL2) in breast ductal carcinoma in situ (2019) (29)
- New Advances in Molecular Breast Cancer Pathology. (2020) (28)
- The prognostic value of the tumor–stroma ratio is most discriminative in patients with grade III or triple‐negative breast cancer (2020) (28)
- Determining breast cancer biomarker status and associated morphological features using deep learning (2021) (28)
- Breast cancer histologic grading using digital microscopy: concordance and outcome association (2018) (28)
- The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts (2016) (28)
- Current trials to reduce surgical intervention in ductal carcinoma in situ of the breast: Critical review. (2017) (28)
- Nottingham prognostic index plus (NPI+) predicts risk of distant metastases in primary breast cancer (2016) (27)
- Basal phenotype: a powerful prognostic factor in small screen-detected invasive breast cancer with long-term follow-up (2007) (27)
- High‐resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry (2005) (27)
- Prognostic and biological significance of peroxisome proliferator-activated receptor-gamma in luminal breast cancer (2015) (26)
- Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification (2015) (26)
- Thioredoxin-interacting protein is an independent risk stratifier for breast ductal carcinoma in situ (2018) (26)
- The molecular mechanisms underlying reduced E-cadherin expression in invasive ductal carcinoma of the breast: high throughput analysis of large cohorts (2019) (26)
- Enhanced glutamine uptake influences composition of immune cell infiltrates in breast cancer (2019) (26)
- The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER+ breast cancer (2019) (26)
- Low expression of G protein-coupled oestrogen receptor 1 (GPER) is associated with adverse survival of breast cancer patients (2018) (26)
- Targeting PARP1 in XRCC1-Deficient Sporadic Invasive Breast Cancer or Preinvasive Ductal Carcinoma In Situ Induces Synthetic Lethality and Chemoprevention. (2018) (26)
- Inhibition of HER2 Increases JAGGED1-dependent Breast Cancer Stem Cells: Role for Membrane JAGGED1 (2018) (26)
- Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance (2016) (25)
- Imaging overview of metaplastic carcinomas of the breast: a large study of 71 cases. (2016) (25)
- Prolyl-4-hydroxylase Α subunit 2 (P4HA2) expression is a predictor of poor outcome in breast ductal carcinoma in situ (DCIS) (2018) (25)
- EpCAM expression is an indicator of recurrence in basal-like breast cancer (2012) (25)
- Glutamate dehydrogenase (GLUD1) expression in breast cancer (2018) (25)
- Macroscopic handling and reporting of breast cancer specimens pre‐ and post‐neoadjuvant chemotherapy treatment: review of pathological issues and suggested approaches (2015) (25)
- Invasive Lobular Carcinoma (2019) (24)
- Phenotypic characterisation of breast cancer: the role of CDC42 (2017) (24)
- The impact of using defined criteria for adequacy of fine needle aspiration cytology of the thyroid in routine practice (2011) (24)
- Papillary carcinoma of the breast: diagnostic agreement and management implications (2016) (24)
- Connexin 43 is an independent predictor of patient outcome in breast cancer patients (2018) (23)
- Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis (2021) (23)
- Prognostic stratification of oestrogen receptor‐positive HER2‐negative lymph node‐negative class of breast cancer (2017) (23)
- The prognostic significance of immune microenvironment in breast ductal carcinoma in situ (2020) (23)
- Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients (2012) (23)
- Infiltrating epitheliosis of the breast: characterization of histological features, immunophenotype and genomic profile (2016) (23)
- Immunohistochemical Analysis of IDH2 R172 Hotspot Mutations in Breast Papillary Neoplasms: Applications in the Diagnosis of Tall Cell Carcinoma with Reverse Polarity (2019) (22)
- The microRNA maturation regulator Drosha is an independent predictor of outcome in breast cancer patients (2012) (22)
- A review of the biological and clinical characteristics of luminal‐like oestrogen receptor‐positive breast cancer (2012) (22)
- Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer (2014) (22)
- Diagnostic concordance of breast pathologists: lessons from the National Health Service Breast Screening Programme Pathology External Quality Assurance Scheme (2017) (22)
- Targetable ERBB2 mutation status is an independent marker of adverse prognosis in estrogen receptor positive, ERBB2 non-amplified primary lobular breast carcinoma: a retrospective in silico analysis of public datasets (2020) (21)
- ERCC1-XPF deficiency is a predictor of olaparib induced synthetic lethality and platinum sensitivity in epithelial ovarian cancers. (2019) (21)
- Clinicopathological and prognostic significance of mitogen-activated protein kinases (MAPK) in breast cancers (2016) (21)
- Topo2α protein expression predicts response to anthracycline combination neo-adjuvant chemotherapy in locally advanced primary breast cancer (2010) (21)
- Cell Proliferation (KI-67) Expression Is Associated with Poorer Prognosis in Nigerian Compared to British Breast Cancer Women (2013) (21)
- PARP1 blockade is synthetically lethal in XRCC1 deficient sporadic epithelial ovarian cancers. (2020) (21)
- A key genomic subtype associated with lymphovascular invasion in invasive breast cancer (2019) (21)
- Impact of breast cancer grade discordance on prediction of outcome (2018) (20)
- SlideGraph+: Whole Slide Image Level Graphs to Predict HER2Status in Breast Cancer (2021) (20)
- DNA repair prognostic index modelling reveals an essential role for base excision repair in influencing clinical outcomes in ER negative and triple negative breast cancers (2015) (20)
- Assessment of HMGA2 and PLAG1 rearrangements in breast adenomyoepitheliomas (2019) (20)
- Co-Expression Effect of SLC7A5/SLC3A2 to Predict Response to Endocrine Therapy in Oestrogen-Receptor-Positive Breast Cancer (2020) (20)
- Screen-detected breast lesions with malignant needle core biopsy diagnoses and no malignancy identified in subsequent surgical excision specimens (potential false-positive diagnosis). (2009) (20)
- Collagen (XI) alpha-1 chain is an independent prognostic factor in breast ductal carcinoma in situ (2019) (20)
- The role of PIP5K1α/pAKT and targeted inhibition of growth of subtypes of breast cancer using PIP5K1α inhibitor (2018) (19)
- ERK1/2 is related to oestrogen receptor and predicts outcome in hormone-treated breast cancer (2014) (19)
- Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients (2013) (19)
- Impact of intratumoural heterogeneity on the assessment of Ki67 expression in breast cancer (2016) (19)
- Amplified centrosomes and mitotic index display poor concordance between patient tumors and cultured cancer cells (2017) (19)
- Lack of expression of the proteins GMPR2 and PPARα are associated with the basal phenotype and patient outcome in breast cancer (2012) (19)
- Accuracy of frozen section in the diagnosis of liver mass lesions (2006) (19)
- Diagnostic concordance of reporting lymphovascular invasion in breast cancer (2018) (18)
- Invasion in breast lesions: the role of the epithelial–stroma barrier (2018) (18)
- Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkers (2020) (18)
- The prognostic significance of interferon-stimulated gene 15 (ISG15) in invasive breast cancer (2020) (18)
- The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution (2019) (18)
- Construction of tissue microarrays from core needle biopsies – a systematic literature review (2016) (18)
- Adenomyoepithelioma of the breast: a proposal for classification (2021) (17)
- Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma (2019) (17)
- Prognostic significance of KN motif and ankyrin repeat domains 1 (KANK1) in invasive breast cancer (2019) (17)
- BQ323636.1, a Novel Splice Variant to NCOR2, as a Predictor for Tamoxifen-Resistant Breast Cancer (2018) (17)
- PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression. (2020) (17)
- Molecular Complexity of Lymphovascular Invasion: The Role of Cell Migration in Breast Cancer as a Prototype (2020) (17)
- Targeting ataxia telangiectasia-mutated- and Rad3-related kinase (ATR) in PTEN-deficient breast cancers for personalized therapy (2018) (17)
- Three dimensional reconstruction of a human breast carcinoma using routine laboratory equipment and immunohistochemistry (2005) (17)
- Three-dimensional reconstruction of sentinel lymph nodes with metastatic breast cancer indicates three distinct patterns of tumour growth (2009) (17)
- Current issues with luminal subtype classification in terms of prediction of benefit from endocrine therapy in early breast cancer (2018) (16)
- A novel prognostic two-gene signature for triple negative breast cancer (2020) (16)
- Legumain is an independent predictor for invasive recurrence in breast ductal carcinoma in situ (2018) (16)
- Immunohistochemical assessment of HRAS Q61R mutations in breast adenomyoepitheliomas (2019) (16)
- Low-estrogen receptor-positive breast cancer: the impact of tissue sampling, choice of antibody, and molecular subtyping. (2012) (15)
- Prognostic and biological significance of proliferation and HER2 expression in the luminal class of breast cancer (2014) (15)
- Semantic annotation for computational pathology: multidisciplinary experience and best practice recommendations (2021) (15)
- Predicting Metastasis Risk in Pancreatic Neuroendocrine Tumors Using Deep Learning Image Analysis (2021) (15)
- Myxovirus resistance 1 (MX1) is an independent predictor of poor outcome in invasive breast cancer (2020) (15)
- The prognostic significance of lysosomal protective protein (cathepsin A) in breast ductal carcinoma in situ (2019) (15)
- The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer (2019) (15)
- Mucinous metaplasia of the vulva in a case of lichen sclerosus. A case report (2005) (14)
- Whole‐exome sequencing and RNA sequencing analyses of acinic cell carcinomas of the breast (2019) (14)
- First international TNBC conference meeting report (2018) (14)
- Panoptic Overview of Triple-Negative Breast Cancer in Nigeria: Current Challenges and Promising Global Initiatives (2018) (14)
- The nucleolar-related protein Dyskerin pseudouridine synthase 1 (DKC1) predicts poor prognosis in breast cancer (2020) (14)
- Rho-GTPase activating-protein 18: a biomarker associated with good prognosis in invasive breast cancer (2017) (14)
- FKBPL: a marker of good prognosis in breast cancer (2015) (14)
- Clinicopathological and molecular significance of Sumolyation marker (ubiquitin conjugating enzyme 9 (UBC9)) expression in breast cancer of black women. (2014) (14)
- Clinical utility of reverse phase protein array for molecular classification of breast cancer (2015) (14)
- Kinesin family member-18A (KIF18A) is a predictive biomarker of poor benefit from endocrine therapy in early ER+ breast cancer (2018) (13)
- Adverse prognostic and predictive significance of low DNA-dependent protein kinase catalytic subunit (DNA-PKcs) expression in early-stage breast cancers (2014) (13)
- Feasibility of integrated high‐wavenumber Raman imaging and fingerprint Raman spectroscopy for fast margin assessment in breast cancer surgery (2020) (13)
- Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers (2017) (13)
- Spindle cell lesions of the breast: a diagnostic approach (2021) (13)
- Digital pathology for primary diagnosis of screen‐detected breast lesions – experimental data, validation and experience from four centres (2020) (13)
- The prognostic significance of ALDH1A1 expression in early invasive breast cancer (2020) (13)
- ATM Regulated PTEN Degradation Is XIAP E3 Ubiquitin Ligase Mediated in p85α Deficient Cancer Cells and Influence Platinum Sensitivity (2019) (13)
- Pleomorphic adenoma‐like tumour of the breast (2016) (13)
- Breast conservation in ductal carcinoma in situ (DCIS): what defines optimal margins? (2017) (12)
- Histological clues to the diagnosis of metastasis to the breast from extramammary malignancies (2020) (12)
- Invasive Lobular Carcinoma Mimicking Papillary Carcinoma: A Report of Three Cases (2016) (12)
- Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies (2020) (12)
- The mTOR downstream regulator (p-4EBP1) is a novel independent prognostic marker in ovarian cancer (2019) (12)
- Clinicopathological and Functional Significance of RECQL1 Helicase in Sporadic Breast Cancers (2016) (12)
- Influence of E-cadherin expression on the mammographic appearance of invasive nonlobular breast carcinoma detected at screening. (2009) (12)
- The intra-tumoural stroma in patients with breast cancer increases with age (2019) (12)
- Evaluation of touch preparation cytology during frozen-section diagnoses of pulmonary lesions (2010) (12)
- Breast cancer: Updated guideline recommendations for HER2 testing (2014) (11)
- The prognostic significance of early stage lymph node positivity in operable invasive breast carcinoma: number or stage (2012) (11)
- Further evidence to support bimodality of oestrogen receptor expression in breast cancer (2017) (11)
- PIASγ expression in relation to clinicopathological, tumour factors and survival in indigenous black breast cancer women (2013) (11)
- Saccharomyces cerevisiae-like 1 (SEC14L1) is a prognostic factor in breast cancer associated with lymphovascular invasion (2018) (11)
- Molecular profiling of breast cancer in Nigerian women identifies an altered p53 pathway as a major mechanism underlying its poor prognosis compared with British counterpart. (2014) (11)
- The effect of human placental chorionic villi derived mesenchymal stem cell on triple-negative breast cancer hallmarks (2018) (11)
- Clinicopathological significance of lipocalin 2 nuclear expression in invasive breast cancer (2019) (11)
- Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimators. (2015) (11)
- Pleomorphic adenomas and mucoepidermoid carcinomas of the breast are underpinned by fusion genes (2020) (11)
- Artificial intelligence for advance requesting of immunohistochemistry in diagnostically uncertain prostate biopsies (2021) (11)
- The expression of ERα, ERβ and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real‐time PCR (2009) (10)
- The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma (2020) (10)
- Screen-detected malignant breast lesions diagnosed following benign (B2) or normal (B1) needle core biopsy diagnoses. (2010) (10)
- Ductal Carcinoma In Situ (2012) (10)
- The low nuclear grade breast neoplasia family (2012) (10)
- CAV1 and CAV2 are associated with breast cancer basal-like and triple negative immunophenotype (2008) (10)
- The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways (2015) (10)
- High nuclear MSK1 is associated with longer survival in breast cancer patients (2018) (10)
- Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay (2014) (10)
- Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes (2018) (9)
- Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management (2020) (9)
- Infiltrative epitheliosis of the breast (2012) (9)
- Assessment of mitotic activity in breast cancer: revisited in the digital pathology era (2021) (9)
- Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis (2018) (9)
- Visual histological assessment of morphological features reflects the underlying molecular profile in invasive breast cancer: a morphomolecular study (2020) (9)
- Chemokine (C‐C motif) receptor 7 (CCR7) associates with the tumour immune microenvironment but not progression in invasive breast carcinoma (2017) (9)
- Dopamine and cAMP-regulated phosphoprotein 32 kDa (DARPP-32) and survival in breast cancer: a retrospective analysis of protein and mRNA expression (2019) (9)
- FEN1 Blockade for Platinum Chemo-Sensitization and Synthetic Lethality in Epithelial Ovarian Cancers (2021) (9)
- Geometric characteristics of collagen have independent prognostic significance in breast ductal carcinoma in situ: an image analysis study (2019) (8)
- Prognostic significance of nucleolar assessment in invasive breast cancer (2019) (8)
- Gigantic recurrent abdominal desmoid tumour: a case report (2007) (8)
- The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma (2020) (8)
- The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes (2020) (8)
- XRCC1 deficient triple negative breast cancers are sensitive to ATR, ATM and Wee1 inhibitor either alone or in combination with olaparib (2020) (8)
- Nucleolar protein 10 (NOP10) predicts poor prognosis in invasive breast cancer (2020) (8)
- Upregulation of Cyclin B2 (CCNB2) in breast cancer contributes to the development of lymphovascular invasion. (2022) (8)
- PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer (2020) (8)
- ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC (2016) (8)
- Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer Patients (2018) (8)
- Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer (2019) (8)
- Predicting the Economic Impact of the COVID-19 Pandemic in the United Kingdom Using Time-Series Mining (2021) (8)
- Clinicopathological and prognostic significance of Ras association and pleckstrin homology domains 1 (RAPH1) in breast cancer (2018) (8)
- Automated quality assessment of large digitised histology cohorts by artificial intelligence (2022) (8)
- Androgen dependent mechanisms of pro-angiogenic networks in placental and tumor development. (2017) (8)
- ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers (2019) (8)
- Morphogenesis of the papillary lesions of the breast: phenotypic observation (2015) (8)
- Visual assessment of mitotic figures in breast cancer: a comparative study between light microscopy and whole slide images (2021) (8)
- Molecular disruption of DNA polymerase β for platinum sensitisation and synthetic lethality in epithelial ovarian cancers (2021) (8)
- Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer (2021) (7)
- Outcome of radial scar/complex sclerosing lesion associated with epithelial proliferations with atypia diagnosed on breast core biopsy: results from a multicentric UK-based study (2019) (7)
- Precision Molecular Pathology of Breast Cancer. (2016) (7)
- The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situ (2020) (7)
- The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer (2020) (7)
- Machine learning-based prediction of breast cancer growth rate in vivo (2019) (7)
- Viewpoint: Availability of oestrogen receptor and HER2 status for the breast multidisciplinary meeting discussion; time to get it right. (2016) (7)
- The relationship of CDK18 expression in breast cancer to clinicopathological parameters and therapeutic response (2018) (7)
- Artificial intelligence grading of breast cancer: a promising method to refine prognostic classification for management precision (2021) (7)
- A survey on artificial intelligence in histopathology image analysis (2022) (7)
- PP1, PKA and DARPP‐32 in breast cancer: A retrospective assessment of protein and mRNA expression (2021) (7)
- Recommendations for HER 2 assessment in breast cancer (2015) (7)
- Combined total internal reflection AF spectral-imaging and Raman spectroscopy for fast assessment of surgical margins during breast cancer surgery (2020) (7)
- Human epidermal growth factor receptor 2 testing in invasive breast cancer: should histological grade, type and oestrogen receptor status influence the decision to repeat testing? (2016) (7)
- RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer (2021) (6)
- Potential quality pitfalls of digitalized whole slide image of breast pathology in routine practice (2021) (6)
- Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer (2022) (6)
- Standardization of the tumor-stroma ratio scoring method for breast cancer research (2022) (6)
- Biological and clinical significance of PARP 1 protein expression in breast cancer (2016) (6)
- Efficacy of an incident-reporting system in cellular pathology: a practical experience (2012) (6)
- RAD50 deficiency is a predictor of platinum sensitivity in sporadic epithelial ovarian cancers (2020) (6)
- A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma In Situ (2020) (6)
- Tumour cell membrane laminin expression is associated with basal-like phenotype and poor survival in Nigerian breast cancer. (2016) (6)
- Breast Tumours Resembling the Tall Cell Variant of Thyroid Papillary Carcinoma: Are They Part of the Papillary Carcinoma Spectrum or a Distinct Entity? (2018) (6)
- Pleomorphic adenomas and mucoepidermoid carcinomas of the breast are underpinned by fusion genes (2020) (6)
- Werner Syndrome Protein Expression in Breast Cancer. (2020) (6)
- The ITIM-Containing Receptor: Leukocyte-Associated Immunoglobulin-Like Receptor-1 (LAIR-1) Modulates Immune Response and Confers Poor Prognosis in Invasive Breast Carcinoma (2020) (6)
- Utility of ankyrin 3 as a prognostic marker in androgen-receptor-positive breast cancer (2019) (6)
- Specific cell differentiation in breast cancer: a basis for histological classification (2021) (6)
- Expression of CDK 7 , cyclin H and MAT 1 is elevated in breast cancer and is prognostic in estrogen receptor positive breast cancer (2016) (5)
- Integrated Analysis of Key Differentially Expressed Genes Identifies DBN1 as a Predictive Marker of Response to Endocrine Therapy in Luminal Breast Cancer (2020) (5)
- Surgical management of ductal carcinoma in situ of the breast: A large retrospective study from a single institution (2019) (5)
- Ligase 1 is a predictor of platinum resistance and its blockade is synthetically lethal in XRCC1 deficient epithelial ovarian cancers (2021) (5)
- Clinicopathological significance of ataxia telangiectasia-mutated (ATM) kinase and ataxia telangiectasia-mutated and Rad3-related (ATR) kinase in MYC overexpressed breast cancers (2019) (5)
- Retrospective assessment of cyclin‐dependent kinase 5 mRNA and protein expression and its association with patient survival in breast cancer (2020) (5)
- Assessment of proliferation in breast cancer: cell cycle or mitosis? An observational study (2021) (5)
- Molecular-Based Diagnostic, Prognostic and Predictive Tests in Breast Cancer (2015) (5)
- Clinical and Molecular Significance of Poly (ADP-Ribose) Polymerase-1 (PARP-1) in Breast Cancer of African Women and its Potential as a Targeted Therapy (2013) (5)
- Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4 (2021) (5)
- Invasive Ductal Carcinoma of No Special Type and Histologic Grade (2012) (5)
- Clinicopathologic significance of androgen receptor expression in invasive breast cancer: A comprehensive analysis in large cohorts (2016) (5)
- PathProfiler: Automated Quality Assessment of Retrospective Histopathology Whole-Slide Image Cohorts by Artificial Intelligence, A Case Study for Prostate Cancer Research (2021) (5)
- Nuclear morphology in breast lesions: refining its assessment to improve diagnostic concordance (2021) (5)
- Clinicopathological and molecular characteristics of Ku 70/80 expression in Nigerian breast cancer and its potential therapeutic implications. (2017) (5)
- The value of examination of multiple levels of mammary needle core biopsy specimens taken for investigation of lesions other than calcification (2012) (5)
- Integrating Breast Cancer Genetics into Clinical Practice (2012) (4)
- Retrospective observational study of HER2 immunohistochemistry in borderline breast cancer patients undergoing neoadjuvant therapy, with an emphasis on Group 2 (HER2/CEP17 ratio ≥2.0, HER2 copy number <4.0 signals/cell) cases (2021) (4)
- Refining the definition of HER2‐low class in invasive breast cancer (2022) (4)
- Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas). (2008) (4)
- 275 Targeting XRCC1 (X-ray Repair Cross-complementing Gene 1), a Key DNA Base Excision Repair Protein for Personalized Therapy in Breast and Ovarian Cancer (2012) (4)
- Defining the area of mitoses counting in invasive breast cancer using whole slide image (2021) (4)
- From Expression Profiling to Routine Practice (2009) (4)
- Dataset for pathology reporting of ductal carcinoma in situ, variants of lobular carcinoma in situ and low‐grade lesions: recommendations from the International Collaboration on Cancer Reporting (ICCR) (2022) (4)
- Caspase-3 and caspase-8 expression in breast cancer: caspase-3 is associated with survival (2016) (4)
- Deep learning models for histologic grading of breast cancer and association with disease prognosis (2022) (4)
- Breast Neoplasms with Dermal Analogue Differentiation (Mammary Cylindroma): Report of 3 Cases and a Proposal for a New Terminology (2015) (4)
- Eighth Edition Cancer Staging Manual of Breast Cancer by the American Joint Committee on Cancer: are the new changes to improve staging or a treatment decision tool? (2018) (4)
- The Biological and Clinical Significance of Glutaminase in Luminal Breast Cancer (2020) (4)
- Oestrogen-regulated protein SLC39A6: a biomarker of good prognosis in luminal breast cancer (2021) (4)
- Ki67 assessment in invasive luminal breast cancer: a comparative study between different scoring methods (2022) (4)
- Correlations of morphological features and surgical management with clinical outcome in a multicentre study of 241 phyllodes tumours of the breast (2020) (4)
- P1-06-18: Loss of E-Cadherin Expression in Clinical Breast Cancer Is Associated with an Adverse Outcome on Tamoxifen. (2011) (4)
- The prognostic significance of Flap Endonuclease 1 (FEN1) in breast ductal carcinoma in situ (2021) (4)
- Flower lose, a cell fitness marker, predicts COVID‐19 prognosis (2021) (3)
- Atypia in breast pathology: what pathologists need to know (2021) (3)
- Re‐audit of revised method for assessing the mitotic component of histological grade in needle core biopsies of invasive carcinoma of the breast (2012) (3)
- Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair (2018) (3)
- Assessment of Predictive Biomarkers in Breast Cancer: Challenges and Updates (2022) (3)
- Diagnostic concordance of phyllodes tumour of the breast (2021) (3)
- Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers (2021) (3)
- Phyllodes tumor in the breast (2012) (3)
- Abstract PD4-13: Estrogen receptor-negative breast adenomyoepitheliomas are driven by co-occurring HRAS hotspot and PI3K pathway gene mutations: A genetic and functional analysis (2018) (3)
- Abstract P5-18-02: A quantitative centrosomal amplification score (CAS) predicts local recurrence in ductal carcinoma in situ (2019) (3)
- Outcome of radial scar/complex sclerosing lesion associated with epithelial proliferations with atypia diagnosed on breast core biopsy – Results from a multicentric UK based study (2019) (3)
- Age-Related Biology of Early-Stage Operable Breast Cancer and Its Impact on Clinical Outcome (2021) (3)
- 1st UK Interdisciplinary Breast Cancer Symposium—15th–16th January 2018 (2017) (3)
- MSI-WES: a simple approach for microsatellite instability testing using whole exome sequencing. (2021) (3)
- Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer (2013) (3)
- Head to head: do neuroendocrine tumours in the breast truly exist? (2022) (3)
- SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment (2019) (3)
- Digital Technology in Diagnostic Breast Pathology and Immunohistochemistry (2021) (3)
- Ubiquitin-conjugating enzyme 2C (UBE2C) is a poor prognostic biomarker in invasive breast cancer (2022) (3)
- Evaluation oncotype DX® 21‐gene recurrence score and clinicopathological parameters: a single institutional experience (2023) (3)
- Clinicopathological and Functional Evaluation Reveal NBS1 as a Predictor of Platinum Resistance in Epithelial Ovarian Cancers (2021) (3)
- Results of a worldwide survey on the currently used histopathological diagnostic criteria for invasive lobular breast cancer (2022) (3)
- Helix-loop-helix protein inhibitor of differentiation 4 (ID4) expression is an indicator of poor survival in Nigerian breast cancer women (2014) (3)
- Prognostic significance of receptor expression discordance between primary and recurrent breast cancers: a meta-analysis (2021) (3)
- Ecdysoneless Protein Regulates Viral and Cellular mRNA Splicing to Promote Cervical Oncogenesis (2021) (3)
- The clinical value of progesterone receptor expression in luminal breast cancer: A study of a large cohort with long‐term follow‐up (2023) (3)
- The characteristics and clinical significance of atypical mitosis in breast cancer (2022) (3)
- The Mammalian Ecdysoneless Protein Interacts with RNA Helicase DDX39A To Regulate Nuclear mRNA Export (2021) (3)
- 23. Inclusion of KI67 significantly improves performance of the predict prognostication and prediction model for early breast cancer (2014) (2)
- SLC1A5 co-expression with TALDO1 associates with endocrine therapy failure in estrogen receptor-positive breast cancer (2021) (2)
- Abstract P2-09-37: Immunohistochemical Markers Progesterone Receptor, HER2, Ki67 and bcl-2-Associated Athanogene 1 and Prediction of Adjuvant Tamoxifen Treatment Outcome in ER+ Early Breast Cancer (2010) (2)
- Grading of Invasive Carcinoma (2017) (2)
- Combined Perioperative Lapatinib and Trastuzumab in Early HER2-Positive Breast Cancer Identifies Early Responders: Randomized UK EPHOS-B Trial Long-Term Results (2022) (2)
- Reply to Rosen (2017) (2)
- An update on the pathological classification of breast cancer (2022) (2)
- The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate Cancer (2022) (2)
- Abstracts from USCAP 2021: Bone and Soft Tissue Pathology (33-65) (2021) (2)
- Inclusion of KI 67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer (2014) (2)
- Correction: The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situ (2020) (2)
- Clinicopathological utility of human epidermal growth factor receptor 2 (HER2)-heterogeneity for next-generation treatments of triple-negative breast cancer (2021) (2)
- Using Image's Processing Methods in Bio-Technology (2009) (2)
- Toward Personalized Breast Cancer Management: The Role of Lymphovascular Invasion (2013) (2)
- Which lesions with a radiological or core biopsy diagnosis of fibroadenoma should be excised? (2021) (2)
- Breast pathology today: morphology and molecules (2013) (2)
- An international unified approach to reporting and grading invasive breast cancer. An overview of the International Collaboration on Cancer Reporting (ICCR) initiative (2022) (2)
- Plus : development and validation of a prognostic model for early breast cancer that includes HER 2 (2012) (2)
- O-37 SOX11 and PSMD3 expression in HER2 positive breast cancer (2010) (2)
- Abstract P1-01-23: Hypoxia induced centrosome amplification via HIF-1α/Plk4 signaling axis associates with poorer overall survival in TNBC (2018) (2)
- Abstract P5-09-01: Nottingham prognostic index plus (NPI+): Validation of the modern clinical decision making tool in breast cancer (2015) (1)
- A multi-institutional study of racial differences in androgen receptor status among triple-negative breast cancers. (2016) (1)
- Improving mitotic cell counting accuracy and efficiency using phosphohistone‐H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading (2022) (1)
- OC-0392: Tumour characteristics associated with local relapse after hypofractionated radiotherapy in early breast cancer (2015) (1)
- The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes (2018) (1)
- Ecdysoneless Overexpression Drives Mammary Tumorigenesis through Upregulation of C-MYC and Glucose Metabolism (2022) (1)
- Evolving DNA repair synthetic lethality targets in cancer (2022) (1)
- Abstracts from USCAP 2021: Pulmonary, Mediastinal, Pleural, and Peritoneal Pathology (910-952) (2021) (1)
- Clinical and molecular significance of the RNA m6A methyltransferase complex in prostate cancer (2023) (1)
- Intra-operative assessment of sentinel lymph nodes for breast cancer surgery: An update. (2021) (1)
- Prolyl-4-hydroxylase Α subunit 2 (P4HA2) expression is a predictor of poor outcome in breast ductal carcinoma in situ (DCIS) (2018) (1)
- Annual Review Issue: Breast Pathology (2022) (1)
- Metaplastic Breast Carcinomas (2017) (1)
- Clinical validation of EndoPredict in premenopausal women with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) primary breast cancer. (2021) (1)
- Defining invasion in breast cancer: the role of basement membrane (2022) (1)
- Increased expression of glutamine transporter SNAT2/SLC38A2 promotes glutamine dependence and oxidative stress resistance, and is associated with worse prognosis in triple-negative breast cancer (2020) (1)
- Low calpain-9 is associated with adverse disease-specific survival following endocrine therapy in breast cancer (2014) (1)
- Molecular Pathology of Breast Cancer Metastasis (2015) (1)
- Targeting Mre11 overcomes platinum resistance and induces synthetic lethality in XRCC1 deficient epithelial ovarian cancers (2022) (1)
- Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape (2018) (1)
- Current topics in breast pathology: expert perspectives. (2017) (1)
- O-55 Translational landscape of Epithelial Mesenchymal Transition in molecular classes of invasive breast cancer (2010) (1)
- Aurora Kinase A (AURKA) is an independent predictor of recurrence in breast ductal carcinoma in situ (DCIS) (2018) (1)
- Prognostic significance of microinvasion with ductal carcinoma in situ of the breast: a meta-analysis (2022) (1)
- Prognostic Significance of Tumour Infiltrating Lymphocytes in Ductal Carcinoma in Situ of the Breast (2018) (1)
- Abstracts from USCAP 2021: Medical Renal Pathology (Including Renal Transplantation) (828-847) (2021) (1)
- Molecular Pathology of Precancerous Lesions of the Breast (2015) (1)
- Inclusion of KI67 significantly improves performance of the PREDICT prognostication and prediction model for early breast cancer (2014) (1)
- The clinical significance of cyclin B1 (CCNB1) in invasive breast cancer with emphasis on its contribution to lymphovascular invasion development (2022) (1)
- Pitfalls in breast pathology (2022) (1)
- EHD2 overexpression promotes tumorigenesis and metastasis in triple-negative breast cancer by regulating store-operated calcium entry (2022) (1)
- A key genomic subtype associated with lymphovascular invasion in invasive breast cancer (2019) (1)
- O-88 Breast cancer among Nigerian women: Clinical and biological differences compared with age-matched UK women (2010) (1)
- Abstracts from USCAP 2021: Pulmonary, Mediastinal, Pleural, and Peritoneal Pathology (910-952) (2021) (1)
- Aurora Kinase A Is an Independent Predictor of Invasive Recurrence in Breast Ductal Carcinoma in situ (2022) (1)
- Raman Spectral Histopathology of Breast Cancer Recession Margins (2016) (1)
- The prognostic significance of immune microenvironment in breast ductal carcinoma in situ (2020) (1)
- 303 Could the Axilla Be Managed Less Aggressively in Selected Node-positive Breast Cancer Patients? (2012) (0)
- AQuantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma In Situ A C (2020) (0)
- Unravelling the clinicopathological and functional significance of replication protein A (RPA) heterotrimeric complex in breast cancers (2023) (0)
- Abstracts from USCAP 2021: Endocrine Pathology (296-310) (2021) (0)
- IL6/STAT3 co-opts ER regulatory elements to drive metastasis in breast cancer (2019) (0)
- Abstract 92: CHIP/STUB1 ubiquitin ligase targets MZF1 and loss of its expression in breast cancer unleashes a MZF1-cathepsin pro-oncogenic program (2018) (0)
- Retinoid X receptor gamma (RXRG) is an independent prognostic biomarker in ER-positive invasive breast cancer (2019) (0)
- Biology and clinical outcomes of estrogen receptor positive (ER+) early primary breast cancer (BC) in older (≥70 years) women—A study based on core needle biopsies (CNB). (2018) (0)
- Prognostic significance of heat shock protein 90AA1 (HSP90α) in invasive breast cancer (2021) (0)
- Should the axilla be managed less aggressively in selected node-positive breast cancer patients? (2012) (0)
- Abstract A28: Evaluation of CDK12 protein expression as a novel biomarker for PARP1/2 inhibitor sensitivity in breast cancer (2016) (0)
- Global kinome silencing combined with 3D invasion screening of the tumor microenvironment identifies fibroblast-expressed PIK3Cδ involvement in triple-negative breast cancer progression (2019) (0)
- PO-110 AKT expression is associated with poor clinical outcome in ovarian cancer (2018) (0)
- ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC (2016) (0)
- Abstract 3560: PLK4 is a HIF-1α target gene: A novel mechanism inducing centrosome amplification in tumor cells (2020) (0)
- O-38 Influence of a basal phenotype on the metastatic pattern of breast cancer (2007) (0)
- Association of hypoxia-induced centrosome amplification with clinical outcomes in triple-negative breast cancer. (2017) (0)
- Prognostic utility of androgen receptor signaling pathway in invasive breast cancer (2020) (0)
- VGLL1-directed TEAD activation drives endocrine therapy resistance in estrogen receptor positive breast cancer (2020) (0)
- Immunohistochemistry in Breast Cancer: Practice Points and Pitfalls (2022) (0)
- Abstract C026: Lack of HER4 signaling predicts poor prognosis among triple-negative breast cancer patients of African descent: A multi-institutional study (2020) (0)
- Targeting DNA damage repair precision medicine strategies in cancer (2023) (0)
- UK recommendations for HER2 assessment in breast cancer: an update (2022) (0)
- stac2 expression predicts worse outcome in basal-like breast cancer (2009) (0)
- Issue Information (2018) (0)
- Tubular Carcinoma (2019) (0)
- Elevated expression of STK3 mRNA and protein is associatedwith poor outcome in invasive breast cancer (2017) (0)
- High expression of Rsf-1 correlates with poor prognosis in breast cancer (2016) (0)
- Prediction of breast cancer growth rate In vivo and its clinical implications. (2018) (0)
- Too many statistical errors for meaningful interpretation. Response to letter to the editor. (2013) (0)
- Quantifying Lymphatic Vessel Density in Human Tissue Samples. (2022) (0)
- Breast cancer profiling: A minimised panel of predictive markers for survival (2006) (0)
- Multi-institutional study of triple negative breast cancer stratification by a metric that quantifies cell cycling kinetics. (2016) (0)
- Loss of MED23 leads to poor prognosis in invasive breastcancer (2017) (0)
- CYP2S1 and CYP2W1 expression is associated with patient survival in breast cancer (2022) (0)
- A Case Series Exploration of Multi-Regional Expression Heterogeneity in Triple-Negative Breast Cancer Patients (2022) (0)
- Abstracts from USCAP 2021: Neuropathology and Ophthalmic Pathology (848-862) (2021) (0)
- Abstract P3-05-18: Unravelling the clinicopathological and functional significance of Replication Protein A (RPA) heterotrimeric complex in sporadic breast cancers (2023) (0)
- RANK signaling increases after anti-HER2 therapy contributing to the emergence of resistance in HER2-positive breast cancer (2021) (0)
- Histological risk factors, prognostic indicators and staging (2013) (0)
- Intra-operative spectroscopic assessment of surgical margins during breast conserving surgery (2018) (0)
- Clinical Study Cell Proliferation ( KI-67 ) Expression Is Associated with Poorer Prognosis in Nigerian Compared to British Breast Cancer Women (2015) (0)
- Utility of stromal lymphocytes in diagnosis and predicting upgrade of B3 breast lesions from core biopsies (2022) (0)
- O-17 Borderline HER2 protein positive breast cancers have similar patient outcome regardless of HER2 gene amplification status (2010) (0)
- Intra-operative Assessment of Excision margins During Breast Conserving Surgery by Integrated Raman Microscopy and Auto-fluorescence Imaging (2018) (0)
- Abstract P2-13-08: Combined peri-operative lapatinib and trastuzumab in early HER2-positive breast cancer - Long term results of the randomized UK EPHOS-B trial (2022) (0)
- O-18 PARP1 expression in hormone estrogen receptor negative breast cancer: Preferential expression in basal-like and HER2-positive tumours (2010) (0)
- Abstract B120: Ada3, a component of ATAC complex is involved in regulation of the Genomic stability, DNA repair process and breast cancer (2013) (0)
- Abstract P3-06-09: Test of association between Ki67 index of early breast cancer and local relapse after adjuvant hypofractionated radiotherapy. (2012) (0)
- A retrospective analysis of ezrin protein and mRNA expression in breast cancer: Ezrin expression is associated with patient survival and survival of patients with receptor-positive disease. (2023) (0)
- RANK is a poor prognosis marker and a therapeutic target in ER‐negative postmenopausal breast cancer (2023) (0)
- Letter to the Editor (2008) (0)
- Abstracts from USCAP 2021: General Surgical Pathology (405-421) (2021) (0)
- Abstract 2517: The role of endocytic traffic regulator EHD1 in EGFR traffic and breast cancer (2018) (0)
- Abstracts from USCAP 2021: Cytopathology (158-237) (2021) (0)
- L1-regularized neural ranking for risk stratification and its application to prediction of time to distant metastasis in luminal node negative chemotherapy naïve breast cancer patients (2021) (0)
- The significance of tumour microarchitectural features in breast cancer prognosis: a digital image analysis (2018) (0)
- Clinicopathological characteristics of basal-like breast cancer: a comparative study between Egyptian and British patients (2019) (0)
- Abstracts from USCAP 2021: General Surgical Pathology (405-421) (2021) (0)
- Abstracts from USCAP 2021: Bone and Soft Tissue Pathology (33-65) (2021) (0)
- Abstract P4-05-07: Whole-exome and RNA-sequencing analyses of acinic cell carcinomas of the breast (2020) (0)
- Authors' reply: combining two antibodies to define E‐cadherin loss of expression in non‐lobular breast carcinomas: when less is more (2013) (0)
- Molecular Pathology of Hormone Regulation in Breast Cancer: Hormone Receptor Evaluation and Therapeutic Implications (2015) (0)
- Abstracts from USCAP 2021: Head and Neck Pathology (635-663) (2021) (0)
- Abstract P1-18-06: Targetable ERBB2 mutations independently predict an aggressive phenotype in primary, ERBB2 non-amplified, hormone receptor positive lobular breast cancer (2020) (0)
- Co-expression of nuclear P38 and hormone receptors is prognostic of good long-term clinical outcome in primary breast cancer and is linked to upregulation of DNA repair (2018) (0)
- Applications and implications of whole-slide imaging in breast pathology (2021) (0)
- Association of L-type amino acid transporter 1 (LAT1) with the immune system and prognosis in invasive breast cancer (2022) (0)
- Predictive markers of response to neoadjuvant chemotherapy in locally advanced breast cancer (LAPC) (2008) (0)
- biopsy specimens predictive factors in breast cancer needle core An overview of assessment of prognostic and (2009) (0)
- Novel Splice Variant to NCOR 2 , as a Predictor for Tamoxifen Resistant Breast Cancer (2017) (0)
- Recent advances in breast cancer (2016) (0)
- Assessment of human epidermal growth factor receptor 2 in breast cancer (2008) (0)
- SHON expression predicts response and relapse risk of breast cancer patients after anthracycline-based combination chemotherapy or tamoxifen treatment (2019) (0)
- Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas (2018) (0)
- Potential of a novel technique for constructing tissue microarrays from core needle biopsy as seen in older women with primary breast cancer. (2016) (0)
- SlideGraph<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" altimg="si3.svg"><mml:msup><mml:mrow /><mml:mo>+</mml:mo></mml:msup></mml:math>: Whole Slide Image Level Graphs to Predict HER2 Status in Breast Cancer (2022) (0)
- Abstract 43: Predictive biomarkers of recurrence may not be useful for deescalating treatment of breast ductal carcinoma in situ due to de novo ipsilateral breast carcinoma development (2022) (0)
- Towards Personalized Management of Ovarian Cancer (2022) (0)
- Clinical Validation of EndoPredict in Pre-Menopausal Women with ER-Positive, HER2-Negative Primary Breast Cancer (2022) (0)
- New results on the NBUFR and NBUE classes of life distributions (2009) (0)
- Breast carcinomas with basal phenotype: An appraisal of morphology and prognostic significance (2006) (0)
- Combined proliferation and apoptosis index provides better risk stratification in breast cancer. (2023) (0)
- Abstract P6-10-21: Evaluation of genomic changes in ductal carcinomain situas potential biomarkers of recurrence risk (2020) (0)
- Predicting chemotherapy response in invasive breast cancer. (2014) (0)
- Abstract B08: Identifying high-risk triple negative breast cancer patients using a novel cycling kinetics metric (2017) (0)
- Abstract 5405: Expression of cathepsin D in early-stage breast cancer and its prognostic and predictive value (2022) (0)
- A Novel Splice Variant to NCOR2 as Biomarker for Tamoxifen Resistant Breast Cancer (2017) (0)
- Will MRI screening deliver the expected survival advantage in BRCA 1 carriers? (2009) (0)
- Abstracts from USCAP 2021: Quality and Patient Safety (953-989) (2021) (0)
- Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies (2020) (0)
- Novel Immunohistochemical Based Biomarkers in Breast Cancer (2016) (0)
- PO-236 Human ligase profiling to predict platinum sensitivity and clinical outcome in primary epithelial ovarian cancers (2018) (0)
- Oestrogen Receptor Positive Breast Cancer: Prognostic and Biological Significance of Proliferation Assessed by Cyclin B1 and Thymidine Kinase 1 (TK1) Protein Expression (2010) (0)
- The frequency and clinical significance of centromere enumeration probe 17 alterations in human epidermal growth factor receptor 2 immunohistochemistry‐equivocal invasive breast cancer (2022) (0)
- Assessment of HMGA2 and PLAG1 rearrangements in breast adenomyoepitheliomas (2019) (0)
- Abstract PR02: β-Catenin overexpression underlies the aggressive disease course in African American triple-negative breast cancer patients who lack androgen receptor (2018) (0)
- Abstract P3-04-01: Discovery of distinct sub-groups of ER positive breast cancers by DNA repair expression profiling: Implications for patient stratification and personalization of therapy (2013) (0)
- Abstract PS6-11: TargetableERBB2mutation status is an independent marker of adverse prognosis in estrogen receptor positive,ERBB2non-amplified primary lobular breast carcinoma: Validation using a novel gene signature of HER2 activation (2021) (0)
- Abstracts from USCAP 2021: Neuropathology and Ophthalmic Pathology (848-862) (2021) (0)
- A combined HER3-EGFR score in triple-negative breast cancer: racial differences. (2016) (0)
- The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer (2023) (0)
- Exploring molecular pathways in low-grade oestrogen receptor positive breast cancer: a biomarker driven approach (2016) (0)
- Histopathology would like to thank the following reviewers for their help in 2007: (2007) (0)
- Lessons from a breast cell annotation competition series for school pupils (2022) (0)
- Molecular profiling and quantitative image analysis reveal spatial intratumor heterogeneity in TNBC. (2020) (0)
- O-27 Breast cancer with basal phenotypic expression: mammographic findings (2007) (0)
- RANK is an independent biomarker of poor prognosis in estrogen receptor-negative breast cancer and a therapeutic target in patient-derived xenografts (2021) (0)
- O-12 Translational exploration of PIK3/Akt pathway activation in early invasive breast cancer (2010) (0)
- Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes (2018) (0)
- Small molecule inhibition of group I p21-activated kinases in breast cancer induces apoptosis and potentiates the activity of microtubule stabilizing agents (2015) (0)
- A Hybrid Pipeline to Assess Oestrogen Receptor Stained Nuclei in Invasive Breast Cancer (2019) (0)
- PPFIA1 expression associates with poor response to endocrine treatment in luminal breast cancer (2020) (0)
- Abstract P3-09-18: The association between genomic alterations and body mass index in patients with early breast cancer (2022) (0)
- Brief fixation and hormone receptor expression in breast cancer. (2015) (0)
- Exploring anti-androgen therapies in hormone dependent prostate cancer and new therapeutic routes for castration resistant prostate cancer (2022) (0)
- Combined HER3-EGFR score in triple-negative breast cancer provides prognostic and predictive significance superior to individual biomarkers (2020) (0)
- On a Life Distribution Family Based on Total Time on Test on Average: NBUTA (2008) (0)
- O-92 UPARAP/ENDO180 expression in invasive breast carcinoma and its relation to patient outcome (2007) (0)
- The Prognostic Significance of the Signaling Proteins: PTEN, P85α, ATM and XIAP in Primary Ovarian Cancer (2021) (0)
- Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer (2012) (0)
- Reply to "Increased survival of women with luminal breast cancer and progesterone receptor immunohistochemical expression of greater than 10%". (2023) (0)
- Abstracts from USCAP 2021: Dermatopathology (238-270) (2021) (0)
- Untangling the clinicopathological significance of MRE11-RAD50-NBS1 complex in sporadic breast cancers (2021) (0)
- Abstracts from USCAP 2021: Pathobiology and Emerging Techniques (891-902) (2021) (0)
- A UK Real-world Evaluation of Efficacy and Toxicity of Second-line Trastuzumab Emtansine and Third-line Trastuzumab Deruxtecan in HER2-positive Advanced Breast Cancer (2023) (0)
- Cell division cycle 25C (CDC25C) expression confers poor prognosis in invasive breast cancer (2017) (0)
- High Inner Centromere Protein (INCENP) expression correlates with aggressive features and predicts poor prognosis in patients with invasive breast cancer. (2023) (0)
- A whole slide image-based machine learning approach to predict ductal carcinoma in situ (DCIS) recurrence risk (2019) (0)
- O-93 ALCAM is an independent predictor of survival in unselected breast cancer (2007) (0)
- Enhanced glutamine uptake influences composition of immune cell infiltrates in breast cancer (2019) (0)
- Abstracts from USCAP 2021: Liver Pathology (795-827) (2021) (0)
- Thioredoxin interacting protein (TXNIP) is an independent risk stratifier for breast ductal carcinoma in situ. Modern Pathology . ISSN 1530-0285 (2018) (0)
- PO-014 Targeting PARP1 in XRCC1 deficient sporadic invasive breast cancer or pre-invasive ductal carcinoma in situ for synthetic lethality and chemoprevention (2018) (0)
- Abstracts from USCAP 2021: Endocrine Pathology (296-310) (2021) (0)
- Abstract B12: Racial differences in Androgen Receptor status among triple-negative breast cancers (2017) (0)
- The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution (2019) (0)
- Abstracts from USCAP 2021: Pancreas, Gallbladder, Ampulla, and Extra-Hepatic Biliary Tree (863-890) (2021) (0)
- Abstracts from USCAP 2021: Dermatopathology (238-270) (2021) (0)
- Clinicopathological, predictive and prognostic significance of XRCC1-Ligase III heterodimer expression in ovarian cancer (2018) (0)
- O-30 Basal-like phenotype is a prognostic marker of locally advanced breast cancer but not a predictive marker of response to neoadjuvant anthracycline chemotherapy (2010) (0)
- The frequency and clinical significance of DNA polymerase beta (POLβ) expression in breast ductal carcinoma in situ (DCIS) (2021) (0)
- mTORC1 and its downstream effectors predict poor outcome in primary epithelial ovarian cancer (2018) (0)
- O-43 Global histone modifications in breast cancer tissue correlate with tumor phenotype, prognostic factors and patient outcome (2007) (0)
- Abstracts from USCAP 2021: Pathobiology and Emerging Techniques (891-902) (2021) (0)
- Expression, assessment and significance of Ki67 expression in breast cancer: an update (2023) (0)
- SP-0394: Cost-effectiveness of radiotherapy in Europe: a uniform solution for a heterogeneous context? (2010) (0)
- Dynamic relationship between cycling kinetics of triple-negative breast cancer and tumor infiltrating immune cells. (2017) (0)
- Identifying likely metastatic sites for triple negative breast cancers using immunohistochemical biomarkers. (2016) (0)
- Abstracts from USCAP 2021: Cardiovascular Pathology (148-157) (2021) (0)
- Abstract 3379: Massively parallel sequencing analysis of breast adenomyoepitheliomas reveals the heterogeneity of the disease and identifies a subset driven byHRAShotspot mutations (2017) (0)
- FOXP1 expression correlates with better prognosis in invasive breast cancer including the ER-positive luminal subtype (2017) (0)
- An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation (2017) (0)
- THE ROLE OF THE ANDROGEN RECEPTOR IN PRIMARY BREAST CANCER IN OLDER WOMEN (2019) (0)
- Epigenome erosion drives neural crest-like phenotypic mimicry in triple-negative breast cancer and other SOX10+ malignancies (2021) (0)
- Checkpoint Kinase 1 Expression Predicts Poor Prognosis in Nigerian Breast Cancer Patients (2017) (0)
- Invasive Cribriform Carcinoma (2019) (0)
- HER3-EGFR score to predict clinical outcomes in triple-negative breast cancer. (2017) (0)
- Correction: The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situ (2020) (0)
- Thioredoxin Interacting Protein (TXNIP) is an Independent Risk Stratifier for Breast Ductal Carcinoma in situ (2018) (0)
- A gap analysis for breast cancer research: identifying translational priorities (2013) (0)
- The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours (2018) (0)
- Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer (2022) (0)
- Mechanistic and Clinical Evidence Supports a Key Role for Cell Division Cycle Associated 5 (CDCA5) as an Independent Predictor of Outcome in Invasive Breast Cancer (2022) (0)
- Correction: The clinical significance of oestrogen receptor expression in breast ductal carcinoma in situ (2020) (0)
- Abstracts from USCAP 2021: Head and Neck Pathology (635-663) (2021) (0)
- Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors (2018) (0)
- Abstract B09: Multivariable Models for Predicting Likely Metastatic Sites for Triple Negative Breast Cancers (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Emad A. Rakha?
Emad A. Rakha is affiliated with the following schools:
